Source link : https://www.newshealth.biz/health-news/fenofibrate-slows-diabetic-retinopathy-progression/
ORLANDO — The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative 27% over 4 years compared with placebo (22.7% vs 29.2%, P=0.006), reported David Preiss, MBChB, PhD, of the University of Oxford in England, […]
Author : News Health
Publish date : 2024-06-22 18:00:15
Copyright for syndicated content belongs to the linked Source.
Categories